News & Insights
Fed holds rates steady despite concerns over inflation
29 Oct 2026
The Federal Reserve voted Wednesday to keep benchmark interest rates on hold, opting to take a patient approach in its fight against inflation despite mounting evidence that price pressures are proving more nettlesome than policymakers…
Read moreASX to lift after Fed rates call
29 Oct 2026
Australian shares are set to tick higher after the US Federal Reserve held interest rates steady. S&P/ASX 200 futures were up 22 points, or 0.3 per cent, to 8882 near 6am (AEDT). Fed chairman Kevin…
Read moreThe stocks that did the most damage in 2024 – and the ones that ruled
Australian shares smashed records in 2024 but the benchmark S&P/ASX 200 Index will finish the year with only a 6 per cent advance to show for it because for every Commonwealth Bank millionaire, there were…
ESG investing on shaky footing as green fatigue sweeps ETF market
Funds prioritising environmental, social and governance concerns face their biggest test as investors lose interest, triggering a wave of closures. Australian investors allocated $800 million into ESG exchange-traded funds over the past year, representing just…
ASX says it will trade as normal on Monday, narrowly avoiding disaster
The ASX has narrowly avoided the need to delay or cancel trading on Monday after engineers working through the weekend to resolve serious issues with its critical settlements processing system. The faults were discovered on…
Bull market tested as volatility spikes, overheated assets cool off. The testing may not be done
A turbulent week on Wall Street ends with a “Thank Goolsbee, it’s Friday” rally, after the Chicago Fed President used a CNBC appearance to refocus investors’ attention on the still-encouraging trend in inflation and the likelihood that…
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
Points The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of…
FDA says Eli Lilly’s weight loss drug Zepbound is no longer in shortage
Points The Food and Drug Administration on Thursday said the active ingredient in Eli Lilly’s weight loss drug Zepbound is no longer in shortage, a decision that will eventually bar compounding pharmacies from making cheaper, unbranded versions of…
ASX to drop, $A recovers as Wall Street bounces back
Australian shares are poised to fall as markets parse the Federal Reserve’s projections of fewer-than-expected interest rate cuts and higher inflation next year. ASX futures were down 49 points or -0.6 per cent near 8am…
Traders dial up bets for February RBA rate cut
Optimism in money markets is growing for the Reserve Bank of Australia to cut interest rates at its first board meeting of 2025, as traders reassess their global rate outlook. The Australian three-year bond yield…
Shares, dollar slammed after Fed walks back rate cut plans
Financial markets are coming to grips with the possibility that global interest rates may not go much lower and advanced economies like the US and Australia will be prone to higher inflation in a world…
Dow ekes out narrow gain to snap 10-day losing streak, its longest in 50 years: Live updates
The Dow Jones Industrial Average narrowly snapped its longest losing streak since 1974 on Thursday. The 30-stock Dow added 15.37 points, or 0.04% to close at 42,342.24. The S&P 500 slid 0.09% to 5,867.08, while the Nasdaq Composite fell 0.10% to…